Naitou Sei 内藤整

… Alternative Names

Naito Sei 内藤整

Less

Researcher Number	00431643
Other IDs
Affiliation (Current)	2025: 山形大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2021 – 2023: 山形大学, 医学部, 講師 2016 – 2020: 山形大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related / Urology Except Principal Investigator Basic Section 56030:Urology-related / Urology
Keywords	Principal Investigator 腎癌 / Ankrd1 / 癌 / ソラフェニブ / 薬物耐性 / LDL / sorafenib / renal cell carcinoma Except Principal Investigator 尿路上皮癌 / 腎癌 … More / メタボローム / メタボロミクス / 好中球 / GPI-80 / 炎症 / 免疫チェックポイント阻害剤治療 / 末梢血 / BCG / 膀胱癌 / 免疫抑制活性 / 抗腫瘍活性 / メタボタイプ / 泌尿器癌 / 重粒子線治療 / 腫瘍免疫 / 重粒子治療 / 前立腺癌 / 分子サブタイプ / 治療効果予測マーカー / MDSC / 免疫チェックポイント阻害薬 / 腎細胞癌 / 単球 / MDSCs / 癌 / miR143 / アポトーシス / ERK5 Less

Clinical application of cancer immunity-induced neutrophils and immunosuppressive neutrophils
- Principal Investigator
  
  武田裕司
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
泌尿器癌に対する重粒子線治療における免疫学的効果予測因子の探求
- Principal Investigator
  
  加藤智幸
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
Metabolome analysis for identification of urothelial carcinoma metabotypes and exploration of diagnostic and therapeutic targets
- Principal Investigator
  
  土谷順彦
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
Expression and function analysis of MDSC as a predictive factor of novel immunotherapy with GPI-80
- Principal Investigator
  
  Kato Tomoyuki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
Exploration of novel therapeutic molecules for urothelial cancer based on the molecular subtypes and metabolomics
- Principal Investigator
  
  Tsuchiya Norihiko
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
Elucidation of Ankrd1 function in renal cancer and development of new therapeutic strategy to overcome drug resistancePrincipal Investigator
- Principal Investigator
  
  Naito Sei
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yamagata University
Development of a new strategy for renal cell cancer treatment targeting ERK5
- Principal Investigator
  
  Nagaoka Akira
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Yamagata University
Elucidation of the mechanism that LDL counteracts the antitumor effect of sorafenib in renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  Naito Sei
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Yamagata University

All 2023 2021 2020 2019 2018 2017 2016

All Journal Article Presentation

[Journal Article] Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma2023
- Author(s)
  Saima Sabrina, Yuji Takeda, Tomoyuki Kato, Sei Naito, Hiromi Ito, Yuki Takai, Masaki Ushijima, Takafumi Narisawa, Hidenori Kanno, Toshihiko Sakurai, Shinichi Saitoh, Akemi Araki, Norihiko Tsuchiya and Hironobu Asao
- Journal Title
  
  Biomedicines
  
  Volume: 11 Issue: 5 Pages: 1296-1296
- DOI
  10.3390/biomedicines11051296
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09554, KAKENHI-PROJECT-22K09440, KAKENHI-PROJECT-23K08751
[Journal Article] Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma2023
- Author(s)
  Kurota Yuta、Takeda Yuji、Ichiyanagi Osamu、Saitoh Shinichi、Ito Hiromi、Naito Sei、Asao Hironobu、Tsuchiya Norihiko
- Journal Title
  
  Biomedicines
  
  Volume: 11 Issue: 5 Pages: 1330-1330
- DOI
  10.3390/biomedicines11051330
- Data Source
  KAKENHI-PROJECT-22K09440
[Journal Article] Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette?Gu?rin2023
- Author(s)
  Takeda Yuji、Kato Tomoyuki、Sabrina Saima、Naito Sei、Ito Hiromi、et. al.
- Journal Title
  
  Biomedicines
  
  Volume: 11 Issue: 11 Pages: 3062-3062
- DOI
  10.3390/biomedicines11113062
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K08751
[Journal Article] GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma2019
- Author(s)
  Tomoyuki Kato, Yuji Takeda, Hiromi Ito, Yuta Kurota, Atsushi Yamagishi, Toshihiko Sakurai, Sei Naito, Akemi Araki, Hidetoshi Nara, Hironobu Asao, Norihiko Tsuchiya
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 249 Issue: 3 Pages: 203-212
- DOI
  10.1620/tjem.249.203
- NAID
  130007751389
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09704, KAKENHI-PROJECT-17K11122
[Journal Article] LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors aainst renal cell carcinoma2017
- Author(s)
  Sei Naito, Peter Makhov, Igor Astsaturov, Konstantin Golovine, Alexei Tulin, Alexander Ktikov, Robert G Uzzo, Vladimir M Kolenko
- Journal Title
  
  British journal of cancer
  
  Volume: 印刷中
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20123
[Journal Article] LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma2017
- Author(s)
  Sei Naito, Peter Makhov, Igor Astsaturov, Konstatin Golovine, Alexei Tulin, Alexander Kutikov, Robert G Uzzo, Vladimir M Kolenko
- Journal Title
  
  British journal of Cancer
  
  Volume: 116 Issue: 9 Pages: 1203-1207
- DOI
  10.1038/bjc.2017.77
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20123
[Presentation] 膀胱癌BCG膀胱内注入治療時に出現する抗腫瘍型好中球の同定2021
- Author(s)
  武田裕司, 加藤智幸, Sabrina Saima, 内藤整, 伊藤裕美, 牛島正毅, 成澤貴史, 黒田悠太, 菅野秀典, 斉藤真一, 土谷順彦, 浅尾裕信
- Organizer
  山形大学医学部実験動物セミナー・第32回研究成果発表会
- Data Source
  KAKENHI-PROJECT-19K09704
[Presentation] Heterogeneity of neutrophils in renal cell and urothelial carcinoma patients during immune checkpoint inhibition therapy2021
- Author(s)
  Saima S, Kato T, Takeda Y, Naito S, Ito H, Takai Y, Ushijima M, Ozawa M, Narisawa T, Kanno H,Sakurai T, Tsuchiya N, Asao H
- Organizer
  he 80th Annual Meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-19K09704
[Presentation] BCG膀胱内注入療法による尿中抗腫瘍型好中球の誘導2020
- Author(s)
  "加藤智幸, 武田裕司, 内藤整, 荒木明美, 福原宏樹, 斉藤真一, 成澤貴史, 櫻井俊彦, 浅尾裕信, 土谷順彦
- Organizer
  日本泌尿器腫瘍学会　第6回学術集会
- Data Source
  KAKENHI-PROJECT-19K09704
[Presentation] Dynamic changes in myeloid cells in urological cancer patients during immune checkpoint treatment2020
- Author(s)
  Kato Tomoyuki, Takeda Yuji, Naito Sei, Ito Hiromi, Ushijima Masaki, Narisawa Takafumi, Yagi Mayu, Kanno Hidenori, Sakurai Toshihiko, Yamanobe Takuya, Asao Hironobu, Tsuchiya Norihiko
- Organizer
  第79回日本癌学会学術集会
- Data Source
  KAKENHI-PROJECT-19K09704
[Presentation] Ankrd1 as a potential therapeutic target for rapamycin-resistant renal cancer.2019
- Author(s)
  小澤迪喜、内藤整　他
- Organizer
  日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K16684
[Presentation] Patients with nuclear expression of ERK5 had poor prognosis in renal cell carcinoma2018
- Author(s)
  内藤整、菅野秀典、一柳統、長岡明他
- Organizer
  日本癌学会総会
- Data Source
  KAKENHI-PROJECT-16K10993
[Presentation] ERK5 is a promising target for clear cell renal cell carcinoma2018
- Author(s)
  Hidenori Kanno, Sei Naito, Osamu Ichiyanagi, Akra Nagaoka, et al.
- Organizer
  American urological association annual meeting
- Data Source
  KAKENHI-PROJECT-16K10993
[Presentation] Ankrd1 as a potential therapeutic target for rapamycin-resistant renal cell carcionoma2018
- Author(s)
  小澤迪喜、内藤整、他
- Organizer
  日本癌学会総会
- Data Source
  KAKENHI-PROJECT-18K16684
[Presentation] Variation of gene expression profiling caused by adding LDL in renal cell carcinoma2018
- Author(s)
  Mayu Yagi, Sei Naito, Hiromi Ito, Takafumi Narisawa, Yuta Kurota, Hidenori Kanno, Masaki Ushijima, Michiobu Ozawa, Tomoyuki Kato, Norihiko Tsuchiya
- Organizer
  日本癌学会総会
- Data Source
  KAKENHI-PROJECT-16K20123
[Presentation] ERK5 is a promising therapeutic target for clear cell renal carcinoma2018
- Author(s)
  Hidenori Kanno, Sei Naito, Osamu Ichiyanagi, Takafumi Narisawa, Hiromi Ito, Akira Nagaoka, Suguru Ito, Shinta Suenaga, Hiroki Fukuhara, Yuta Kurota, Mayu Yagi, Atsushi Yamagishi, Toshihiko Sakurai, Hayato Nishida, Hisashi Kawazoe, Akihiko Abe, Takuya Yamanobe, Tomoyuki Kato, Norihiko Tsuchiya
- Organizer
  american urological association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10993
[Presentation] ERK5 inhibition as a potential therapeutic taeget for clear cell renal cell carcinoma2018
- Author(s)
  hidenori kanno, sei naito, hiromi ito, takafumi narisawa, osamu ichiyanagi, toshihiro sakurai, hayato nishida, hisashi kawazoe, akihiko abe, takuya yamanobe, akira nagaoka, tomoyuki kato, norihiko tsuchiya
- Organizer
  日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-16K10993
[Presentation] The effects of ERK5 inhibition in clear cell renal cell carcinoma2017
- Author(s)
  Hidenori Kanno, Sei Naito, Hiromi Ito, Osamu Ichiyanagi, Yuuta Kurota, Mayu Yagi, Atsushi Yamagishi, Toshihiko Sakurai, Hayato Nishida, Tomohiro Shibasaki, Hisashi Kawazoe, Tomoyuki Kato, Akira Nagaoka, Norihiko Tsuchiya
- Organizer
  American association for cancer research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10993
[Presentation] LDL compromises efficacy of multitargeted tyrosine kinase inhibitors against renal cell carcinoma2016
- Author(s)
  内藤　整
- Organizer
  第75回日本癌学会学術集会
- Place of Presentation
  横浜コンベンションセンター
- Year and Date
  2016-09-28
- Data Source
  KAKENHI-PROJECT-16K20123

1. Tsuchiya Norihiko (70282176)

# of Collaborated Projects: 4 results

# of Collaborated Products: 5 results
2. 武田裕司 (90302299)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
3. Kato Tomoyuki (40396560)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
4. 一柳統 (70359561)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
5. 櫻井俊彦 (60534154)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. Nagaoka Akira (10258618)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
7. 黒田悠太 (00594326)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
8. 成澤貴史 (20594328)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 斉藤真一 (90536674)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 奈良英利 (00375338)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 浅尾裕信 (80250744)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Naitou Sei 内藤 整

Naito Sei 内藤 整

Research Projects

Research Products

Co-Researchers

Clinical application of cancer immunity-induced neutrophils and immunosuppressive neutrophils

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

泌尿器癌に対する重粒子線治療における免疫学的効果予測因子の探求

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Metabolome analysis for identification of urothelial carcinoma metabotypes and exploration of diagnostic and therapeutic targets

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Expression and function analysis of MDSC as a predictive factor of novel immunotherapy with GPI-80

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of novel therapeutic molecules for urothelial cancer based on the molecular subtypes and metabolomics

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of Ankrd1 function in renal cancer and development of new therapeutic strategy to overcome drug resistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new strategy for renal cell cancer treatment targeting ERK5

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of the mechanism that LDL counteracts the antitumor effect of sorafenib in renal cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette?Gu?rin2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma2019

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors aainst renal cell carcinoma2017

Author(s)

Journal Title

Data Source

Naitou Sei 内藤整

Naito Sei 内藤整